OOIR: Observatory of International Research

Papers

(The H4-Index of Allergy is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Issue Information	371
Type 2 memory B cells: The repository of allergic memory?	264
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	250
	223
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	219
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	153
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	143
In memoriam: Lawrence M. Lichtenstein (1934–2022)	143
Type I and II Interferons Drive Abacavir Hypersensitivity via Treg Suppression and T‐Cell Enhancement in Immunocompetent HLA	142
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	142
Adherence to Mediterranean Diet During Pregnancy, Breastfeeding, and Development of Food Allergy in the Offspring: Results From the MEDALLION Cohort	128
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	124
A Systematic Review and Meta‐Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Tas	121
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	116
Non‐Releasers in the Basophil Activation Test: A Roadmap for the Correct Reporting and Interpretation	116
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	114
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	112
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	112
Atopic Dermatitis ( AD ) Related Cord Blood DNA Methylation Patterns Are Linked to Maternal	109
Preclinical Development of GR2002 , a Novel Anti‐ TSLP Bispecific Antibody With Potent	104
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	97
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	97
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	94
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3	88
Cryopreservation Between Sample Processing and Analysis in Streamlined Basophil Activation Test	87

TOP10 ‐ SCAR : A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Rea	86
Transplacental Antimicrobial Antibodies and Childhood Asthma: Maternal Nativity as an Upstream Factor	85
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP	84
Interleukin‐22 and Interleukin‐18 as Potential Blood Biomarkers in Dupilumab‐Treated Atopic Dermatitis	81
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	80
Type‐2‐Inflammatory‐Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade	75
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	74
Ficolin‐A Protects Against Allergic Asthma via Suppressing ILC2 ‐Drived Type 2 Inflammation	72
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses	71
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	70
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	69
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	69
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	67
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	67
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	64
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	62
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	62
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	61
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	60
Issue Information	58
Issue Information ‐ TOC	57
Issue Information	57
Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function	56
Oral abstracts (OAS)	56
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”	55
	54
Issue Information	53
Non‐immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross‐reactivity with other iodinated contrast media	52